首页> 外文期刊>The journal of asthma >Chest tightness is relieved with the use of asthma drugs except bronchodilators
【24h】

Chest tightness is relieved with the use of asthma drugs except bronchodilators

机译:除了支气管扩张剂外,使用哮喘药物抑制胸闷是缓解的

获取原文
获取原文并翻译 | 示例
       

摘要

Objective: Many patients with a chief complaint of chest tightness are examined in medical facilities, and a lack of diagnosis is not uncommon. We have reported that these patients often include those with chest tightness relieved with bronchodilator use (CTRB) and those with chest tightness relieved with the use of asthma drugs except bronchodilators (CTRAEB). The purpose of this study was to demonstrate the clinical characteristics of the patients with CTRAEB and compare them with data from patients with CTRB. Methods: Patients with CTRB (n?=?13) and CTRAEB (n?=?7) underwent a bronchodilator test, assessments of airway responsiveness to methacholine, bronchial biopsy, and bronchial lavage under fiberoptic bronchoscopy before receiving treatment. In all, 10 healthy subjects, 11 bronchial biopsy control patients, and 10 asthmatic patients were recruited for comparison. Results: Inhalation of a short-acting ?(2)-agonist (SABA) increased the forced expiratory volume in one second (FEV1) by 5.1%???4.0% in patients with CTRB and by 1.3%???3.5% in patients with CTRAEB, and the difference was statistically significant (p?=?0.0449). The bronchial biopsy specimens from the patients with CTRB and CTRAEB exhibited significant increases in T cells (p?
机译:目的:在医疗设施中检查了许多胸部紧绷患者,缺乏诊断并不罕见。我们据报道,这些患者通常包括用支气管扩张剂(CTRB)和胸部紧张的患者缓解胸闷,除了支气管扩张剂(CTRAEB)之外的哮喘药物。本研究的目的是证明CTRAKB患者的临床特征,并将它们与CTRB患者的数据进行比较。方法:CTRB(N?= 13)和CTRAEB(N?=β7)患者进行了支气管扩张剂试验,在接受治疗之前在纤维支气管镜检查下对甲素,支气管活组织检查和支气管灌洗进行评估。总之,10个健康的受试者,11例支气管活检对照患者和10名哮喘患者进行比较。结果:吸入短作用?(2) - 一秒钟(SABA)在一秒钟(FEV1)中的强制呼气量增加了5.1%??? 4.0%的CTRB患者和1.3%??? 3.5%患有CTRAEB的患者,差异有统计学意义(P?= 0.0449)。与对照受试者相比,来自CTRB和CTRAEB患者的支气管活组织检查标本表现出T细胞的显着增加(P?<β.05)。仅在CTRB和CTRAEB患者的一部分患者中增加对甲素的支气管反应性。结论:我们假设CTRAEB患者的临床状况涉及单独从炎症引起的胸闷,并且这种胸闷大多数与气道T细胞相关,而不会收缩气道。除了对支气管扩张剂治疗的反应之外,几乎没有区分CTRAB。该临床试验在(UMIN13994,13998和16741)上注册。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号